https://www.pentixapharm.com/news daily 0.75 2026-03-30 https://www.pentixapharm.com/news/pentixapharm-holding-ag-appoints-erik-merten-to-the-executive-board monthly 0.5 2026-03-30 https://www.pentixapharm.com/news/pentixapharm-holding-ag-will-publish-its-financial-report-for-the-2025-fiscal-year-on-march-26-2026 monthly 0.5 2026-03-19 https://www.pentixapharm.com/news/pentixapharm-receives-fda-study-may-proceed-letters-for-dual-theranostic-inds-in-cxcr4-based-hemato-oncology-program monthly 0.5 2026-02-25 https://www.pentixapharm.com/news/pentixapharm-announces-peer-reviewed-phase-2-data-back-use-of-pentixafor-as-a-superior-non-invasive-pet-diagnostic-for-primary-aldosteronism monthly 0.5 2026-02-05 https://www.pentixapharm.com/news/pentixapharm-receives-fda-feedback-for-phase-3-diagnostic-study-in-hypertension monthly 0.5 2026-01-06 https://www.pentixapharm.com/news/pentixapharm-advances-regulatory-preparations-for-phase-3-panda-study-with-radiodiagnostic-candidate-68ga-pentixafor-in-hypertension monthly 0.5 2025-12-03 https://www.pentixapharm.com/news/pentixapharm-publishes-9-month-figures-for-2025 monthly 0.5 2025-11-11 https://www.pentixapharm.com/news/pentixapharm-to-report-third-quarter-and-first-nine-months-2025-financial-results-on-wednesday-november-12-2025 monthly 0.5 2025-11-09 https://www.pentixapharm.com/news/ad-hoc-pentixapharm-senkt-verlustprognose-fr-das-geschftsjahr-2025-deutlich monthly 0.5 2025-11-06 https://www.pentixapharm.com/news/pentixapharm-strengthens-pipeline-prioritization-and-improves-cost-structure monthly 0.5 2025-10-23 https://www.pentixapharm.com/news/ad-hoc-pentixapharm-fokussiert-entwicklung-auf-fortgeschrittene-klinische-programme-und-strkt-finanzielle-position-durch-einstellung-prklinischer-aktivitten monthly 0.5 2025-10-23 https://www.pentixapharm.com/news/pentixapharm-highlights-expanding-cxcr4-radiopharmaceutical-platform-with-new-clinical-findings-at-eanm-2025 monthly 0.5 2025-10-06 https://www.pentixapharm.com/news/pentixapharm-announces-advancement-of-pentixather-to-fourth-dose-level-in-acute-myeloid-leukemia-trial monthly 0.5 2025-09-25 https://www.pentixapharm.com/news/pentixapharm-publishes-half-year-figures-for-2025 monthly 0.5 2025-08-05 https://www.pentixapharm.com/news/pentixapharm-announces-encouraging-preclinical-data-for-first-in-class-glycan-dependent-anti-cd24-mab-radiopharmaceutical-gt-008 monthly 0.5 2025-06-19 https://www.pentixapharm.com/news/pentixapharm-stellt-neue-klinische-entwicklungsstrategie-vor monthly 0.5 2025-05-28 https://www.pentixapharm.com/news/pentixapharm-to-present-first-in-class-glycan-dependent-cd24-antibody-gt-008-for-solid-tumors-at-aacr-2025 monthly 0.5 2025-04-25 https://www.pentixapharm.com/news/pentixapharm-signs-contract-manufacturing-agreement-for-yttrium-90-based-pentixather-with-eckert-amp-ziegler-se monthly 0.5 2025-04-24 https://www.pentixapharm.com/news/pentixapharm-holding-ag-releases-financial-results-for-2024-and-announces-guidance-for-the-2025-financial-year monthly 0.5 2025-04-15 https://www.pentixapharm.com/news/changes-in-the-supervisory-board-and-management-board-of-pentixapharm-holding-ag monthly 0.5 2025-03-03 https://www.pentixapharm.com/news/first-in-human-data-about-the-treatment-of-muscle-invasive-bladder-cancer-with-pentixapharms-lu177-pentixather-to-be-presented-at-asco-gu-2025 monthly 0.5 2025-02-13 https://www.pentixapharm.com/news/pentixapharm-holding-ag-closes-the-2024-financial-year-with-a-loss-of-eur-14-million-including-risk-provisions-for-myelo-amounting-to-eur-7-million monthly 0.5 2025-01-24 https://www.pentixapharm.com/news/pentixapharm-receives-eur-677-million-for-intangible-assets-formerly-developed-by-glycotope monthly 0.5 2025-02-13 https://www.pentixapharm.com/news/first-patient-treated-in-phase-iii-trial-in-acute-myeloid-and-acute-lymphoblastic-leukemia-with-lu177-pentixather-expanding-the-evidence-base-for-targeted-radiotherapy-approach monthly 0.5 2024-12-06 https://www.pentixapharm.com/news/pentixapharm-releases-interim-report-for-the-third-quarter-of-2024 monthly 0.5 2024-11-12 https://www.pentixapharm.com/news/pentixapharm-welcomes-cms-decision-to-enhance-reimbursement-for-diagnostic-radiopharmaceuticals monthly 0.5 2024-11-04 https://www.pentixapharm.com/news/us-national-cancer-institute-starts-advanced-clinical-trial-with-pentixafor monthly 0.5 2024-10-29 https://www.pentixapharm.com/news/nuclear-medicine-specialist-ken-herrmann-joins-supervisory-board-of-pentixapharm-holding-ag monthly 0.5 2024-10-28 https://www.pentixapharm.com/news/pentixapharm-holding-ag-upcoming-changes-in-the-management-and-supervisory-boards-of-the-pentixapharm-group monthly 0.5 2024-10-25 https://www.pentixapharm.com/news/pentixapharms-cxcr4-core-compound-subject-of-17-abstract-presentations-at-the-hamburg-european-association-of-nuclear-medicine-eanm monthly 0.5 2024-10-19 https://www.pentixapharm.com/news/ema-grants-prime-status-to-pentixapharms-lead-candidate-pentixafor monthly 0.5 2024-10-18 https://www.pentixapharm.com/news/pentixapharm-holding-ag-completes-ipo-in-the-prime-standard-of-the-frankfurt-stock-exchange monthly 0.5 2024-10-03 https://www.pentixapharm.com/news/pentixapharm-holding-ag-placement-price-set-at-eur-510-per-share-all-39-million-offer-shares-placed monthly 0.5 2024-10-01 https://www.pentixapharm.com/news/pentixapharm-holding-ag-sets-price-range-for-planned-ipo monthly 0.5 2024-10-03 https://www.pentixapharm.com/news/pentixapharm-holding-ag-a-subsidiary-of-eckert-amp-ziegler-se-plans-ipo-on-the-prime-standard-of-the-frankfurt-stock-exchange monthly 0.5 2024-09-12 https://www.pentixapharm.com/news/pentixapharm-ag-receives-orphan-drug-designation-for-its-radiodiagnostic-tracer-pentixafor-in-marginal-zone-lymphoma-by-the-european-medicines-agency monthly 0.5 2024-08-26 https://www.pentixapharm.com/news/pentixapharm-acquires-target-discovery-business-of-glycotope monthly 0.5 2024-08-29 https://www.pentixapharm.com/news/pentixapharm-announces-expansion-of-supervisory-board-with-the-appointment-of-distinguished-endocrinologist-marcus-quinkler monthly 0.5 2024-09-12 https://www.pentixapharm.com/news/eckert-amp-ziegler-subsidiary-pentixapharm-receives-encouraging-fda-feedback-to-initiate-phase-iii-trial-with-pentixafor-as-radiopharmaceutical-diagnostic-in-primary-aldosteronism monthly 0.5 2024-06-25 https://www.pentixapharm.com/news/siv95hxf7d476havjx2w1r6k4v7arr monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/eanm-2023-the-theranostics-future-is-now-innovative-diagnostic-application-and-therapeutic-potential-of-cxcr4nbsp monthly 0.5 2024-09-11 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/9655f63d-bd07-4c2c-a4e5-986811b053e5/eanm23_symposium_social_post.png News - EANM 2023: The theranostics future is now: Innovative diagnostic application and therapeutic potential of CXCR4  - Mach es besonders Was auch immer es ist – die Art und Weise, wie du deine Geschichte online vermittelst, kann einen gewaltigen Unterschied ausmachen. https://www.pentixapharm.com/news/8m3ll8gn9pocmiinhdb0hc5ff8hus4 monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/zoqrw67e9mz91nw5or3s9g6grgaz0e monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/qcqpd2zr93mqysmqsp8ve70mp6za11 monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/first-cns-lymphoma-patient-imaged-with-pentixafor-in-phase-ii-trial monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/radboud-university-medical-center-netherlands-to-image-first-patient-with-pentixafor monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/nantes-university-hospital-doses-first-patients-with-eckert-amp-zieglers-novel-ga-68-imaging-agent-pentixafor monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/eckert-amp-ziegler-strahlen-und-medizintechnik-ag-acquires-direct-majority-stake-in-drug-developer-pentixapharm monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/pentixapharm-receives-confirmation-from-ema-that-its-lead-candidate-pentixafor-is-ready-for-phase-iii-study monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/pentixapharm-secures-15-million-series-a-financing-to-develop-cxcr4-targeted-theranostics monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/scintomics-and-1717-life-science-ventures-team-up-in-the-joint-venture-pentixapharm-to-develop-cxcr4-targeted-theranostics monthly 0.5 2024-11-14 https://www.pentixapharm.com/news/category/Ad-hoc+announcement monthly 0.5 https://www.pentixapharm.com/home daily 1.0 2026-02-16 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/478e3436-0bea-4843-bca5-e8b2c46bb9cf/Patients.gif https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/8f4231b5-e8eb-4209-a380-f917a63e124e/Studies2.gif https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/e5433173-590d-45af-9d5d-08de9a8a4ba7/Pipeline4.gif https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/6e94a974-f922-46cb-a297-abd1358f8711/Team3.gif https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/cfd03abe-84e6-4e68-9bba-54a0f273ebc1/DSC_9894-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie.jpg https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/1c78d670-05fa-4129-901e-631d6f2b3121/DSC_0904-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie.jpg https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/99a5683f-d5bc-4ede-a06d-6a16cd7a83fd/DSC_2374-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie.jpg https://www.pentixapharm.com/investors/conferences daily 0.75 2026-03-27 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/8656ce14-6d80-4ea4-814a-4a198fe172e4/logo_colors.45600458.png Conferences & Events https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/2c2df1ec-67da-42fa-8b2f-e84d5a789625/SNMMI2.jpg Conferences & Events https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/09d1290e-e16d-4bcb-bcf3-6cef059969c9/Herunterladen.jpg Conferences & Events https://www.pentixapharm.com/contact daily 0.75 2026-02-16 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/df91d277-b6c4-41e3-9afe-2750cd86654f/Bismarckstrasse_16.jpg https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/709cb7db-cc81-4b1c-ba7b-405150c06c00/campus-berlin-buch.jpg https://www.pentixapharm.com/imprint daily 0.75 2025-08-12 https://www.pentixapharm.com/terms-of-use daily 0.75 2025-03-03 https://www.pentixapharm.com/data-privacy daily 0.75 2025-12-16 https://www.pentixapharm.com/about-us daily 0.75 2026-03-31 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/e6709e88-05ff-4e37-b23b-6736717bba72/Pickel.jpg About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/dc7472c0-69a5-4424-acc7-1ff249434845/Janz.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/98f7d491-c9c8-44dc-97e2-9a8b7879a637/Bierwagen.jpg About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/b5d2602c-fcdf-4831-931c-34029e2a3b24/Nahm.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/d72b1afe-c7b6-4b63-b477-71e1136e11ea/Bloszyk.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/f608948f-9127-4fb0-a913-c1a6debaa1bd/Danielczyk.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/546b3b3b-a4d3-431f-9d63-2df12aa5f287/Pleimes.jpg About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/ab4a9823-5b4f-45f9-8c69-38eb08c937bd/Kollenberg.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/6924085a-3941-44dd-93fe-24ca89eb0a9f/Schewe2.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/f5b21b5b-5915-447e-a7fb-ae3583367e59/Homann.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/1527693b-59e9-435c-a23b-8ce27f8b1eff/Gellert.png About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/1a15f5e7-5884-4566-8190-a18bbaf90035/Dr.+Erik+Merten.jpg About Us https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/99a5683f-d5bc-4ede-a06d-6a16cd7a83fd/DSC_2374-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie.jpg https://www.pentixapharm.com/investors/corporate-governance daily 0.75 2026-03-16 https://www.pentixapharm.com/investors/financial-calendar daily 0.75 2025-12-03 https://www.pentixapharm.com/investors/ir-contact daily 0.75 2025-06-12 https://www.pentixapharm.com/investors/reports daily 0.75 2026-04-02 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/a3f38edf-5c76-4f15-b871-74d2790c6ad3/First+Page+Earnings+Call+March+2026.png https://www.pentixapharm.com/investors/stock-information daily 0.75 2025-02-24 https://www.pentixapharm.com/investors/equitystory daily 0.75 2024-10-16 https://www.pentixapharm.com/legal-disclaimer daily 0.75 2024-09-12 https://www.pentixapharm.com/investors daily 0.75 2025-06-04 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/4a7ad35e-6a67-42f6-9d51-049999e0b774/DSC_9597-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie.jpg https://www.pentixapharm.com/investors/conferences/eanm24 daily 0.75 2024-10-29 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/ced4ad29-6cb3-431c-893a-8cf348b1fa36/16_9_EANM24_PPT_Cover.jpg https://www.pentixapharm.com/pipeline daily 0.75 2025-06-12 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/5bd98fa8-703c-4b7e-8cb7-c0ab994fc77c/DSC_9636-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie2.png https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/6aa1ed71-51a0-4304-8c2c-43faba7db93f/Bild1.png https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/79f830cd-647d-47a3-8b2c-a5d08ee13a41/CXCR4_Grafik6.png https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/b83931e6-5e2c-4cee-8a49-88727c8dcdc1/3D5.png https://www.pentixapharm.com/investors/agm daily 0.75 2025-06-02 https://www.pentixapharm.com/careers daily 0.75 2026-01-12 https://www.pentixapharm.com/iis daily 0.75 2025-09-11 https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/5bd98fa8-703c-4b7e-8cb7-c0ab994fc77c/DSC_9636-b%28c%29Timo_Lutz_Team_fuer-Industriefotografie2.png https://images.squarespace-cdn.com/content/v1/65acfbc12f6ee568582f8ca4/fbf5af9c-6a3e-4861-9c96-efff72efbc05/Bild.png https://www.pentixapharm.com/careers-1 daily 0.75 2026-01-12